Transforming Hemophilia Care: A New Generation of Extended Half-Life Factor Concentrates
New extended half-life products represent a powerful new tool for improving the care and quality of life for persons with hemophilia.
Breakthroughs in the War on Cancer
As the number of cancer cases continues to rise, scientists are bringing to light exciting discoveries that are being used to create targeted therapies to treat and, it is hoped, to eventually cure cancer.
Update on Pertussis
Despite its near eradication in the U.S., whooping cough is making a comeback due to disproven claims and reduced vaccine effectiveness.
Vaccines for International Travel
Vaccination against these four specific diseases is recommended prior to travel to endemic areas.
Childhood Vaccine Refulsal: The Bad Outcomes of Good Intentions
Childhood vaccines are widely recognized as safe, but a growing minority of parents are choosing not have their children immunized.
Influenza Vaccination: What’s New with the Flu?
Recent U.S. Food and Drug Administration advisory committee strain recommendations could make this season’s influenza (flu) vaccine more effective than ever. But, will an epidemic of public apathy undermine immunization efforts?
Influenza Vaccine: A Universal Game Changer?
The efficacy of influenza (flu) vaccines has been greatly improved over the past several decades, but the flu virus still severely sickens hundreds of thousands of individuals each year. Is it possible that scientists have discovered a way to change that?
Myths vs. Facts: Bacterial Skin Infections
Hard-to-treat bacterial skin infections are becoming more common. A better understanding of them is the first step toward improving treatment.
Update on Polio and Post-Polio Syndrome
Polio still plagues a few parts of the world, and some of its past victims are vulnerable to a recurrence but in a less serious form.
Blood Protein Therapeutics: It All Starts with the Plasma
The plasma donor is the first vital part of the process to produce safe and effective plasma protein therapeutics, and the industry prioritizes the safety and health of its plasma donors.
